Improvement of the Solubility and Dissolution Characteristics of Risperidone via Nanosuspension Formulations

Improvement of the Solubility and Dissolution Characteristics of Risperidone via Nanosuspension Formulations

Risperidone is an atypical antipsychotic drug that is used for treating schizophrenia, bipolar mania, and autism. Risperidone rebalances dopamine and serotonin to improve thinking, mood, and behavior by working on dopamine and serotonin α2receptor antagonism. Risperidone has poor solubility and high...

Full description

Bibliographic Details
Main Authors:	Hayder Emad, Shaimaa Nazar Abd-Alhammid
Format:	Article
Language:	English
Published:	College of Pharmacy University of Baghdad 2022-06-01
Series:	Iraqi Journal of Pharmaceutical Sciences
Subjects:	risperidone, nanosuspension, solubility, particle size.
Online Access:	https://bijps.uobaghdad.edu.iq/index.php/bijps/article/view/1331

Similar Items

Enhancement of Solubility and Improvement of Dissolution Rate of Atorvastatin Calcium Prepared as Nanosuspension
by: Ahmed H. Ali, et al.
Published: (2019-12-01)

Preparation and Evaluation of Ketoprofen Nanosuspension Using Solvent Evaporation Technique
by: Hayder K . Abbas, et al.
Published: (2017-12-01)

Nanosuspensions: a New Approach in Drug Delivery
by: M Aghajani, et al.
Published: (2013-03-01)

Nanosuspension: An approach to enhance solubility of drugs
by: Vishal R Patel, et al.
Published: (2011-01-01)

Optimization of Extended-Release ZL-004 Nanosuspensions for In Vivo Pharmacokinetic Study to Enhance Low Solubility and Compliance
by: Chengyue Guo, et al.
Published: (2018-12-01)

Preparation and Evaluation of Hydrogel Containing Prednisolone Nanoparticles
by: Walaa A. Saihood, et al.
Published: (2023-10-01)

Enhancement of solubility of poorly water soluble anti hypertensive drug by nanosizing approach
by: Divyesh Thakar, et al.
Published: (2012-01-01)

Solubility Determination of c-Met Inhibitor in Solvent Mixtures and Mathematical Modeling to Develop Nanosuspension Formulation
by: Maharjan Ravi, et al.
Published: (2021-01-01)

Combination of Dissolving Microneedles with Nanosuspension and Co-Grinding for Transdermal Delivery of Ketoprofen
by: Delly Ramadon, et al.
Published: (2023-03-01)

Preparation and Characterization of Nanosuspension of Aprepitant by H96 Process
by: Sunethra Kalvakuntla, et al.
Published: (2016-03-01)

Fabrication of Caseinate Stabilized Thymol Nanosuspensions via the pH-Driven Method: Enhancement in Water Solubility of Thymol
by: Wei Zhou, et al.
Published: (2021-05-01)

Study of Formulation and Process Variables for Optimization of Piroxicam Nanosuspension Using 3<sup>2</sup> Factorial Design to Improve Solubility and In Vitro Bioavailability
by: Yahya Alhamhoom, et al.
Published: (2023-01-01)

Encapsulation of Risperidone by Methylated β-Cyclodextrins: Physicochemical and Molecular Modeling Studies
by: Laura Sbârcea, et al.
Published: (2020-12-01)

Pharmacokinetics and Anti-Diabetic Studies of Gliclazide Nanosuspension
by: Sunitha Sampathi, et al.
Published: (2022-09-01)

Utilizing Molecular Simulations to Examine Nanosuspension Stability
by: Andrew P. Latham, et al.
Published: (2023-12-01)

Novel redispersible nanosuspensions stabilized by co-processed nanocrystalline cellulose–sodium carboxymethyl starch for enhancing dissolution and oral bioavailability of baicalin
by: Xie J, et al.
Published: (2019-01-01)

Nanosuspension-Based Drug Delivery Systems for Topical Applications
by: Aldeeb MME, et al.
Published: (2024-01-01)

Preparation and Comprehensive Evaluation of the Efficacy and Safety of Chlorantraniliprole Nanosuspension
by: Xiquan Ding, et al.
Published: (2024-01-01)

Preparation and evaluation of famotidine nanosuspension
by: Marwa M. Malik, et al.
Published: (2018-12-01)

Formulation of Aceclofenac Tablets Using Nanosuspension as Granulating Agent: An Attempt to Enhance Dissolution Rate and Oral Bioavailability
by: Rahim H, et al.
Published: (2020-11-01)

Preservation of rutin nanosuspensions without the use of preservatives
by: Pascal L. Stahr, et al.
Published: (2019-09-01)

Formulation of Aceclofenac Tablets Using Nanosuspension as Granulating Agent: An Attempt to Enhance Dissolution Rate and Oral Bioavailability [Retraction]
by: Rahim H, et al.
Published: (2023-12-01)

Development of Nanosuspension Formulations Compatible with Inkjet Printing for the Convenient and Precise Dispensing of Poorly Soluble Drugs
by: Dennis H. Leung
Published: (2022-02-01)

Electrostriction mechanism of light induced lens response in nanosuspension
by: V.I. Ivanov, et al.
Published: (2017-12-01)

Pharmacokinetic evaluation of a 1,3-dicyclohexylurea nanosuspension formulation to support early efficacy assessment
by: Chiang Po-Chang, et al.
Published: (2007-01-01)

Evaluating the Suitability of Using Rat Models for Preclinical Efficacy and Side Effects with Inhaled Corticosteroids Nanosuspension Formulations
by: Chiang Po-Chang, et al.
Published: (2010-01-01)

Preparation, Characterization, and Evaluation of Breviscapine Nanosuspension and Its Freeze-Dried Powder
by: Ting Zhang, et al.
Published: (2022-04-01)

Comparison of Different Nanosuspensions as Potential Ophthalmic Delivery Systems for Ketotifen Fumarate
by: Saieede Soltani, et al.
Published: (2016-09-01)

Influence of Stabilizer on the Development of Luteolin Nanosuspension for Cutaneous Delivery: An In Vitro and In Vivo Evaluation
by: Mohammed Elmowafy, et al.
Published: (2021-10-01)

Effects of Continuing Oral Risperidone vs. Switching from Risperidone to Risperidone Long-Acting Injection on Cognitive Function in Stable Schizophrenia Patients: A Pilot Study
by: Hikaru Hori, et al.
Published: (2018-03-01)

Thermodiffusion contribution in the thermal lens response of the nanosuspension
by: V.I. Ivanov, et al.
Published: (2018-12-01)

Risperidone induced angioedema with concurrent EPS symptoms: a case report and review of literature
by: Gursharan Singh Samra, et al.
Published: (2018-03-01)

Formulation Strategies of Nanosuspensions for Various Administration Routes
by: Sıla Gülbağ Pınar, et al.
Published: (2023-05-01)

Nanosuspension enhances dissolution rate and oral bioavailability of Terminalia arjuna bark extract in vivo and in vitro
by: Fatiqa Zafar, et al.
Published: (2020-01-01)

Report of a Rare Case of Olanzapine and Risperidone Induced Hypomania
by: AR Zahiroddin, et al.
Published: (2006-07-01)

Comparison the effectiveness of aripiprazole and risperidone for the treatment of acute bipolar mania
by: Amir Akhavan Rezayat, et al.
Published: (2014-01-01)

Nanosuspensions as carriers of Annona muricata acetogenins: antibacterial activity against Enterococcus faecalis and listeria monocytogenes
by: Brandon Alexis López-Romero, et al.
Published: (2023-12-01)

Priapism associated with the addition of risperidone to methylphenidate monotherapy: a case report
by: Hatice Ünver, et al.
Published: (2017-05-01)

A case report of eosinophilia associated with risperidone withdrawl in a patient with schizophrenia
by: E. Giourou, et al.
Published: (2022-06-01)

Risperidone/Randomly Methylated β-Cyclodextrin Inclusion Complex—Compatibility Study with Pharmaceutical Excipients
by: Laura Sbârcea, et al.
Published: (2021-03-01)